Cite
HARVARD Citation
Mo, Y. et al. (2022). A phase II, single-center, randomized, double-blind, parallel control clinical study evaluating the immunogenicity and safety of a two-dose schedule of serogroups ACYW meningococcal polysaccharide conjugate vaccine. Vaccine. 40 (47), pp. 6785-6794. [Online].